MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 6, 2015, Pages 6533-6539

  Ma, Chao ^a   Huang, Tao ^a   Ding, Yue Chao ^a   Yu, Wei ^a   Wang, Qian ^a   Meng, Bo ^a   Luo, Su Xia ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cancer stem cells; Chemoresistance; Invasion; MicroRNA 200c; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; GEMCITABINE; MICRORNA; MIRN200 MICRORNA, HUMAN; TUMOR MARKER;

ANALOGS AND DERIVATIVES; CANCER STEM CELL; CELL MOTION; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PANCREATIC NEOPLASMS; PATHOLOGY; PHENOTYPE; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

ANTIMETABOLITES, ANTINEOPLASTIC; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; PHENOTYPE; TRANSFECTION; UP-REGULATION;

EID: 84938632063     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jemal A, Siegel R, Xu J and Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L and He J. Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res 2013; 25: 10-21.
3. Hirata K, Egawa S, Kimura Y, Nobuoka T, Oshima H, Katsuramaki T, Mizuguchi T and Furuhata T. Current status of surgery for pancreatic cancer. Dig Surg 2007; 24: 137-147.
4. Gillen S, Schuster T, Meyer Zum Buschenfelde C, Friess H and Kleeff J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 2010; 7: e1000267.
5. Korbut E, Ptak-Belowska A, Brzozowski T. Mechanisms promoting physiological cells progression into tumorigenesis. J Physiol Pharmacol 2012; 63: 565-570.
6. Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005; 11: 1753-1761.
7. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
8. Papagiannakopoulos T, Kosik KS. MicroRNAs: regulators of oncogenesis and stemness. BMC Med 2008; 6: 15.
9. Palanichamy JK, Rao DS. miRNA dysregulation in cancer: towards a mechanistic understanding. Front Genet 2014; 5: 54.
10. Hede K. Studies define role of microRNA in cancer. J Natl Cancer Inst 2005; 15: 1114-1115.
11. Dou J, Li Y, Zhao F, Hu W, Wen P, Tang Q, Chu L, Wang Y, Cao M, Jiang C and Gu N. Identification of tumor stem-like cells in a mouse myeloma cell line. Cell Mol Biol (Noisy-le-Grand) 2009; 55 Suppl: OL1151-OL1160.
12. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI and Jones RJ. Characterization of clonogenic multiple myeloma cells. Blood 2004; 103: 2332-2336.
13. Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M and Dinney C. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res 2009; 15: 5060-5072.
14. Tryndyak VP, Beland FA, Pogribny IP. E-cadherin transcriptional down-regulation by epigenetive and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer 2010; 126: 2575-2583.
15. Korpal M, Kang Y. The emerging role of miR-200 family of miRNAs in epithelial-to-mesenchymal transition and cancer metastasis. RNA Biol 2008; 5: 115-119.
16. Hurteau GJ, Carlson JA, Spivack SD and Brock GJ. Overexpression of the MiRNA has-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 2007; 67: 7972-7976.